SuPAR in major depression: Association with 26 weeks antidepressant response and 10-year depression outcomes
Haupt TH, Elfving B, Eugen-Olsen J, Mors O, Köhler-Forsberg O
Brain, Behavior, and Immunity - Health. 2023 Nov;33:100685. doi: 10.1016/j.bbih.2023.100685

Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson's disease, STEM-PD
Kirkeby, A, Nelander, J, Hoban, DB, Rogelius, N, Bjartmarz, H, Storm, P, Fiorenzano, A, Adler, AF, Vale, S, Mudannayake, J, Zhang, Y, Cardoso, T, Mattsson, B, Landau, AM, Glud, AN, Sørensen, JC, Lillethorup, TP, Lowdell, M, Carvalho, C, Bain, O, van Vliet, T, Lindvall, O, Björklund, A, Harry, B, Cutting, E, Widner, H, Paul, G, Barker, RA, Parmar, M & Novo Nordisk Cell Therapy R&D 2023
Cell stem cell, bind 30, nr. 10, s. 1299-1314.e9. https://doi.org/10.1016/j.stem.2023.08.014

Changes in neurotrophic signaling pathways in brain areas of the chronic mild stress rat model of depression as a signature of ketamine fast antidepressant response/non-response
Derosa S, Misztak P, Mingardi J, Mazzini G, Müller HK, Musazzi L
Progress in Neuro-Psychopharmacology & Biological Psychiatry. 2024 jan. 10;128:110871. doi: 10.1016/j.pnpbp.2023.110871

Transforming Neurology and Psychiatry: Organ-specific PET Instrumentation and Clinical Applications
Taha A, Alassi A, Gjedde A, Wong DF
PET Clinics. 2023 okt. 7. Epub 2023 okt. 7. doi: 10.1016/j.cpet.2023.06.002